Glob Bioenergi (France) Executives
| ALGBE Stock | EUR 1.37 0.08 5.52% |
Glob Bioenergi employs about 48 people. The company is managed by 10 executives with a total tenure of roughly 48 years, averaging almost 4.0 years of service per executive, having 4.8 employees per reported executive. Discussion of Glob Bioenergi's management performance can provide insight into the enterprise performance.
| Marc Delcourt Chairman Co-Founder, CEO, Chairman of Strategy Committee and Member of Coordination Committee |
| Philippe Marliere President Co-Founder and President of Scientific Advisory Board and Director |
Glob |
Glob Bioenergi Management Team Effectiveness
The company has return on total asset (ROA) of (0.309) % which means that it has lost $0.309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1302) %, meaning that it generated substantial loss on money invested by shareholders. Glob Bioenergi's management efficiency ratios could be used to measure how well Glob Bioenergi manages its routine affairs as well as how well it operates its assets and liabilities.Glob Bioenergi Workforce Comparison
Glob Bioenergi is number one stock in number of employees category among its peers. The total workforce of Materials industry is presently estimated at about 350. Glob Bioenergi retains roughly 48.0 in number of employees claiming about 14% of all equities under Materials industry.
Glob Bioenergi Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Glob Bioenergi Price Series Summation is a cross summation of Glob Bioenergi price series and its benchmark/peer.
Glob Bioenergi Notable Stakeholders
A Glob Bioenergi stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Glob Bioenergi often face trade-offs trying to please all of them. Glob Bioenergi's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Glob Bioenergi's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marc Delcourt | Co-Founder, CEO, Chairman of Strategy Committee and Member of Coordination Committee | Profile | |
| Philippe Marliere | Co-Founder and President of Scientific Advisory Board and Director | Profile | |
| Claudia Erning | Vice President of Investor Relations | Profile | |
| Frdric Ollivier | Chief Officer | Profile | |
| Florence Thueux | Chief Officer | Profile | |
| Romain Chayot | Head Department | Profile | |
| Sabine Mazaleyrat | Head Optimization | Profile | |
| Samuel Dubruque | Chief Financial and Administrative Officer | Profile | |
| Denis Thibaut | Head Department | Profile | |
| Alexandra Moncada | Chief Officer | Profile |
About Glob Bioenergi Management Performance
The success or failure of an entity such as Glob Bioenergi often depends on how effective the management is. Glob Bioenergi management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Glob management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Glob management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Global Bioenergies SA focuses on the development of a biological process for converting renewable resources into isobutene. Global Bioenergies SA was founded in 2008 and is headquartered in Evry, France. GLOBAL BIOENERGIES operates under Utilities - Diversified classification in France and is traded on Paris Stock Exchange. It employs 54 people.
Glob Bioenergi Workforce Analysis
Traditionally, organizations such as Glob Bioenergi use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Glob Bioenergi within its industry.Glob Bioenergi Manpower Efficiency
Return on Glob Bioenergi Manpower
| Revenue Per Employee | 2.1K | |
| Revenue Per Executive | 10.1K | |
| Net Loss Per Employee | 245.3K | |
| Net Loss Per Executive | 1.2M | |
| Working Capital Per Employee | 229.2K | |
| Working Capital Per Executive | 1.1M |
Additional Tools for Glob Stock Analysis
When running Glob Bioenergi's price analysis, check to measure Glob Bioenergi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glob Bioenergi is operating at the current time. Most of Glob Bioenergi's value examination focuses on studying past and present price action to predict the probability of Glob Bioenergi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glob Bioenergi's price. Additionally, you may evaluate how the addition of Glob Bioenergi to your portfolios can decrease your overall portfolio volatility.